Section 32 (S32) is a venture capital firm investing at the frontiers of technology and healthcare, with a strong focus on artificial intelligence, computational biology, and precision medicine. The firm leverages its deep Google and life sciences lineage to back high-conviction founders who are building revolutionary technologies to improve the human condition.
About Section 32
Section 32 is a venture firm founded by former Google Ventures partner Bill Maris with a thesis at the intersection of frontier technology, life sciences, and AI, investing across drug discovery, biotech, healthcare AI, and deep technology. Stage focus runs from Series A through later venture rounds, with checks typically in the $5M to $20M range and the capacity to lead and reserve meaningfully. Healthcare exposure is genuine and concentrated in computational biology, AI-driven drug discovery, novel therapeutics platforms, and selectively medical AI software. Physician founders building AI for drug discovery, computational biology platforms, novel therapeutics, or clinical AI with defended technical depth are the right profile. Founders building consumer wellness brands, pure-play services businesses, or hardware-heavy devices without AI or scientific depth should pitch elsewhere. Geographic posture is US-led with international deal capacity. The realistic entry path is a warm introduction from a Section 32 portfolio CEO, a co-investing science specialist, or a senior scientific advisor in the firm’s network; the partners are technical and prefer founders who can defend the science in detail. Founders should arrive with KOL scientific support, defended IP, and a credible commercial development plan. Treat Section 32 as a serious institutional partner for science- and AI-anchored healthcare companies, with brand, network, and conviction depth at the frontier of computational life sciences.
Founder reviews
Healthcare AI tools backed by Section 32
Tools made by companies in Section 32's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Section 32's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Section 32? Founders only — share your honest experience (anonymous OK, moderated before publishing).